期刊文献+

结直肠癌术后腹腔感染发生的危险因素分析 被引量:22

Analysis of risk factors of intra-abdominai infection after surgery for colorectai cancer
原文传递
导出
摘要 目的探讨结直肠癌患者术后发生腹腔感染的危险因素。方法回顾性分析2011年10月至2014年12月期间于浙江省嘉兴市第一医院肿瘤外科行手术治疗且随访资料完整的773例结直肠癌患者的临床资料,并根据有无发生腹腔感染分为腹腔感染组(110例)和非腹腔感染组(663例)。所有患者均在手术前30min至2h预防性使用抗生素。通过单因素分析和多因素非条件Logistic回归分析结直肠癌患者术后发生腹腔感染的危险因素。结果与本组患者术后腹腔感染发生有关的术前因素包括:患者术前是否患有肝硬化、肾脏疾病、糖尿病等疾病.预防用药情况,是否存在低白蛋白血症、贫血和术前肠梗阻,美国麻醉医师协会麻醉分级(ASA)评分,肿瘤分期(均P〈0.05);术后因素包括:手术是否使用腹腔镜、吻合器,是否为联合脏器切除,是否存在吻合口瘘,引流管置管时间,手术时间(均P〈0.05)。多因素logistic回归分析显示,术前患有糖尿病(OR=2.36,95%CI:1.45~4.76,P〈0.01)、联合脏器切除(OR=2.02,95%CI:1.02~4.00,P〈0.01)、发生吻合口瘘(OR:4.41,95%CI:1.77~10.99,P〈0.01)、手术时间≥140min(OR=2.88,95%CI:1.78~4.67,P〈0.001)以及术后引流管置管天数≥10d(OR=4.57,95%CI:2.78~7.52,P〈0.01)是结直肠癌患者术后发生腹腔感染的独立危险因素:而使用吻合器是患者发生腹腔感染的保护性因素(OR=0.37,95%CI:0.23。0.60,P〈0.01)。与预防性使用头霉素类加甲硝唑相比,预防性使用头孢呋辛加甲硝唑患者的腹腔感染率更高(OR=2.10,95%CI:1.23-3.58,P=0.007)。结论对术前患有糖尿病、手术中联合脏器切除、术后出现吻合口瘘、手术时间≥140min以及术后引流管置管天数≥10d的结直肠癌患者,需重点预防术后发生腹腔感染,术前使用头霉素类加甲硝唑对预防术后发生腹腔感染效果更好。 Objective To investigate the risk factors of intra-abdominal infection (IAI) after colorectal cancer surgery. Methods Clinical and follow-up data of 773 colorectal cancer patients undergoing operation in our hospital from October 2011 to December 2014 were retrospectively analyzed. Patients were divided into intra-abdominal cavity infection group (110 cases, IAI group) and non intra- abdominal infection group (663 cases, non-IAI group). All the patients administered prophylactic antibiotics 30 minutes to 2 hours before operation. Univariate and multivariate analysis were performed to evaluate the risk factors of IAI. Results Preoperative factors associated with postoperative IAI included hepatic cirrhosis, kidney diseases, diabetes or other basic diseases, prophylactic use of drugs, hypoalbuminemia, anemia, intestinal obstruction, and American Society of Anesthesiologists (ASA)anesthetic grading score (all P 〈 0.05). Postoperative factors associated with postoperative IAI included use of laparoscopy or stapler, united exenteration, existence of anastomotic fistula, time of drainage tube placement, operation time and tumor staging (all P 〈 0.05). Multivariate logistic regression analysis showed that preoperative diabetes (OR = 2.36, 95% CI: 1.45 to 4.76, P 〈 0.01), combined exenteration (OR = 2.02, 95% CI:1.02 to 4.00, P 〈 0.01), anastomotic leak (OR = 4.41, 95% CI:1.77 to 10.99, P= 0.001), operation time ≥140 minutes (OR = 2.88, 95% CI: 1.78 to 4.67, P〈 0.01) and period of postoperative drainage ≥10 days (OR = 4.57, 95% CI:2.78 to 7.52, P 〈 0.01) were independent risk factors of postoperative IAI, while the use of stapler was protective factor (OR =0.37, 95% CI: 0.23 to 0.60, P 〈 0.01). Compared with prophylactic use of cephamycins plus metronidazole, cefuroxime plus metronidazole had a higher rate of IAI(OR = 2.10, 95% CI: 1.23 to 3.58, P = 0.007). Conclusions Prevention of postoperative IAI is required for colorectal cancer patients, particularly in those with preoperative diabetes, combined exenteration, anastomotic leak, operation time longer than 140 minutes and postoperative drainage period longer than 10 days. Preoperative use of cephamycins plus metronidazole has better efficacy in prevention of postoperative IAI.
出处 《中华胃肠外科杂志》 CAS CSCD 北大核心 2016年第4期409-413,共5页 Chinese Journal of Gastrointestinal Surgery
关键词 结直肠肿瘤 腹腔感染 危险因素 Colorectal neoplasms Intra-abdominal infection Risk factors
  • 相关文献

参考文献20

  • 1Zimlichman E, Henderson D, Tamir O, et al. Health care- associated infections: a meta-analysis of costs and financial impact on the US health care system[J]. JAMA Intern Med, 2013, 173(22) :2039-2046. DOI: 10.1001/jamaintemmed.2013.9763.
  • 2Worth LJ, Bull AL, Spelman T, et al. Diminishing surgical site infections in Australia: time trends in infection rates, pathogens and antimicrobial resistance using a comprehensive victorian surveillance program, 2002-2013 [J]. Infect Control Hosp Epidemiol, 2015,36 (4) : 409-416. DOI : 10.1017/ice. 2014.70.
  • 3Keenan JE, Speicher PJ, Thacker JK, et al. The preventive surgical site infection bundle in colorectal surgery: an effective approach to surgical site infection reduction and health care cost savings[J]. JAMA Surg, 2014,149( 10):1045-1052. DOI: 10.1001/jamasurg.2014.346.
  • 4Fukuda H, Morikane K, Kuroki M, et al. Impact of surgical site infections after open and laparoscopic colon and rectal surgeries on postoperative resource consumption [J]. Infection, 2012,40(6) : 649-659. DOI : 10.1007/s15010-012-0317-7.
  • 5Lo CH, Chen JH, Wu CW, et al. Risk factors and management of intra-abdominal infection after extended radical gastrectomy [J]. Am J Surg, 2008,196(5) :741-745. DOI: 10.1016/j.amjsurg. 2007.11.031.
  • 6Eagye KJ, Nicolau DP. Deep and organ/space infections in patients undergoing elective colorectal surgery: incidence and impact on hospital length of stay and costs[J]. Am J Surg, 2009, 198 (3) : 359-367. DOI : 10.1016/j.amjsurg.2008.11.030.
  • 7Alonso S, Pascual M, Salvans S, et al. Postoperative intra- abdominal infection and colorectal cancer recurrence: A prospective matched cohort study of inflammatory and angiogenic responses as mechanisms involved in this association [J]. Eur J Surg Oncol, 2015,41(2) :208-214. DOI: 10.1016/j.ejso.2014.10. 052.
  • 8Ata A, Valerian BT, Lee EC, et al. The effect of diabetes on surgical site infections after eoloreetal and noncoloreetal general surgical operations [ J ]. Am Surg, 2010,76 (7) : 697 -702.
  • 9Sehgal R, Berg A, Figueroa R, et al. Risk Factors for Surgical Site Infections after Colorectal Resection in Diabetic Patients [J]. J Am Coll Surg, 2011,212(1):29-34. DOI:10.1016/j. jamcollsurg.2010.09.011.
  • 10Emerging Risk Factors Collaboration; Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes, fasting glucose, and risk of cause-specific death [J ]. N Engl J Med, 2011,364(9) : 829-841. DOI : 10.1056/N[JMoa1008862.

二级参考文献5

  • 1Burke JP. Infection control-a problem for patient safety. N Engl J Med, 2003, 348(7) :651-656.
  • 2Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd Ed. Gastric Cancer, 1998, 1 (1):10-24.
  • 3Wittmann DH. Intraabdominal infections-introduction. World J Surg, 1990, 14(2) : 145-147.
  • 4Pacelli F, Doglietto GB, Alfieri S, et al. Prognosis in intraabdominal infections. Multivariate analysis on 604 patients. Arch Surg, 1996,131 (6) : 641-645.
  • 5Pieracci FM, Barie PS. Intra-abdominal infections. Curr Opin Crit Care, 2007,13(4) :440-449.

共引文献13

同被引文献193

引证文献22

二级引证文献165

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部